Literature DB >> 23516093

Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China.

Hai Long Fu1, De Ping Wu, Xiu Fang Wang, Jian Guo Wang, Feng Jiao, Lei Lei Song, Hui Xie, Xu Yang Wen, Hu Sheng Shan, Yun Xiang Du, Ya Ping Zhao.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is the leading malignancy in Huaian, China. Recently, emerging studies have suggested that an aberrant microRNA (miRNA) expression signature exists in ESCC. However, there is discordant information available on specific miRNA expression in patients from different regions. In this study, we identified 12 miRNAs that are differentially expressed in patients with ESCC from Huaian, China. Among these miRNAs that displayed unique miRNA expression signatures, miR-1, miR-29c, miR-100, miR-133a, miR-133b, miR-143, miR-145, and miR-195 were downregulated, and miR-7, miR-21, miR-223, and miR-1246 were upregulated in cancerous tissue compared with the adjacent normal tissue. Bioinformatics analyses identified the major biological processes and signaling pathways that are targeted by these differentially expressed miRNAs. Accordingly, miR-29c, miR-100, miR-133a, and miR-133b were found to be involved in invasion and metastasis of ESCC, and miR-7 and miR-21 were found to be related to the differentiation of ESCC. Thus, our data present new evidence for the important roles of miRNAs in ESCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516093     DOI: 10.1007/s12013-013-9554-3

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  40 in total

1.  Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.

Authors:  Jianbo Zhu; Lan Yang; Weiyan You; Xiaobin Cui; Yunzhao Chen; Jianming Hu; Wei Liu; Shugang Li; Xiaoyue Song; Yutao Wei; Wenjie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 2.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

3.  The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells.

Authors:  Tian-Yun Wang; Qing-Qing Zhang; Xi Zhang; Qiu-Li Sun; Chun-Peng Zhao; Xiao-Yin Wang
Journal:  Tumour Biol       Date:  2015-07-09

Review 4.  MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.

Authors:  Ivan G Gomez; Naoki Nakagawa; Jeremy S Duffield
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

5.  microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.

Authors:  Niuniu Sun; Lin Ye; Tingmin Chang; Xiaojing Li; Xiumin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

6.  MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.

Authors:  Fanye Zeng; Shuqing You; Xueli Dai
Journal:  Histol Histopathol       Date:  2022-01-31       Impact factor: 2.303

7.  miR-25 is upregulated before the occurrence of esophageal squamous cell carcinoma.

Authors:  Yaxu Jia; Heng Lu; Cheng Wang; Junjun Wang; Chenyu Zhang; Fangyu Wang; Chunni Zhang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 8.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

Review 9.  Role of microRNA-7 in digestive system malignancy.

Authors:  Wan-Qun Chen; Ling Hu; Geng-Xin Chen; Hai-Xia Deng
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

10.  Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy.

Authors:  Guiming Chen; Jin Peng; Weiguo Zhu; Guangzhou Tao; Yaqi Song; Xilei Zhou; Wanwei Wang
Journal:  Med Oncol       Date:  2014-10-04       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.